90K/Mac-2BP mRNA expression in human hepatoma cell-lines and tissues

被引：0
|
作者：
Lauer, G [1 ]
Reiser, M [1 ]
Schmiegel, W [1 ]
机构：
[1] Ruhr Univ Bochum, Knappschaftskrankenhaus, Dept Med, D-4630 Bochum, Germany
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)85212-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
L0354
引用
收藏
页码：A1284 / A1284
页数：1
相关论文
共 50 条
  • [1] Expression and significance of 90K/Mac-2BP in prostate cancer
    Hu, Jianxin
    He, Jian
    Kuang, Youlin
    Wang, Zhenxing
    Sun, Zhaolin
    Zhu, Hengcheng
    Liu, Xiuheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (01) : 181 - 184
  • [2] Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis
    Correale, M
    Giannuzzi, V
    Iacovazzi, PA
    Valenza, MA
    Lanzillotta, S
    Abbate, I
    Quaranta, M
    Caruso, ML
    Elba, S
    Manghisi, OG
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3469 - 3472
  • [3] Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (mac-2BP) protein
    Grassadonia, Antonino
    Tinari, Nicola
    Fiorentino, Bruno
    Nakazato, Minoru
    Chung, Hyun-Kyung
    Giuliani, Cesidio
    Napolitano, Giorgio
    Iacobelli, Stefano
    Howcroft, T. Kevin
    Singer, Dinah S.
    Kohn, Leonard D.
    ENDOCRINOLOGY, 2007, 148 (07) : 3507 - 3517
  • [4] 90K (Mac-2 BP) in human milk
    DOstilio, N
    Sabatino, G
    Natoli, C
    Ullrich, A
    Iacobelli, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03): : 543 - 546
  • [5] Viremia, HCV genotype and 90K/MAC-2BP levels as predictors of response to a-IFN therapy
    Artini, M
    Natoli, C
    Costanzo, A
    Grassadonia, A
    Porcari, P
    DEgidio, M
    Tinari, N
    Balsano, C
    Paroli, M
    Iacobelli, S
    Levrero, M
    HEPATOLOGY, 1996, 24 (04) : 143 - 143
  • [6] Are 90K/MAC-2BP serum levels correlated with poor prognosis in HCC patients? Preliminary results
    Iacovazzi, PA
    Guerra, V
    Elba, S
    Sportelli, F
    Manghisi, OG
    Correale, M
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (03): : 222 - 226
  • [7] Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma:: A comparison with α-fetoprotein
    Lacovazzi, PA
    Trisolini, A
    Barletta, D
    Elba, S
    Manghisi, OG
    Correale, M
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (10) : 961 - 965
  • [8] Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation
    Tinari, N
    Kuwabara, I
    Huflejt, ME
    Shen, PF
    Iacobelli, S
    Liu, FT
    INTERNATIONAL JOURNAL OF CANCER, 2001, 91 (02) : 167 - 172
  • [9] Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients
    Iacovazzi, Palma A.
    Notarnicola, Maria
    Caruso, Maria G.
    Guerra, Vito
    Frisullo, Silvia
    Altomare, Donato F.
    Correale, Mario
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2010, 32 (01) : 160 - 164
  • [10] Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer
    Wu, Keng-Liang
    Chen, Hong-Hwa
    Pen, Chen-Tzi
    Yeh, Wen-Ling
    Huang, Eng-Yen
    Hsiao, Chang-Chun
    Yang, Kuender D.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
12345